Factors affecting the presentation time of patients with acute stroke to hospital and level of awareness of thrombolytic therapy
Abstract
Material and Method: 276 patients with acute stroke were included in our study. Standard structured questionnaire was administered to the patients. Patients were asked about the time of onset of stroke, age, place of residence, level of education, whether they received thrombolytic therapy, what was done as the first intervention, and whether they had information about thrombolytic therapy. Stroke severity was also evaluated by applying the National Institutes of Health Stroke Scale (NIHSS) to the patients.
Results: Of the patients included in the study, 218 (79%) had ischemic stroke, 26 (9.4%) had intracerebral hemorrhage and 32 (11.6%) had TIA. The mean NIHH score of the patients was 6.7±6.2. Stroke onset time was mainly between 18.00-24.00 with a rate of 28.3%. It was understood that 83.1% of the patients came to the emergency department by ambulance and 16.9% came by their own vehicle. When the groups of patients who received and did not receive thrombolytic therapy were compared, no significant difference was found between who the patient lived with at home and the groups of the level of education. Statistical significance was found with symptom onset time (p<0.05). Significant differences were found when the time of presentation to the hospital was compared with the place of residence, type of stroke and symptom onset time (p<0.05).
Conclusion: When the results are evaluated, it is necessary to reduce the delay time of patients with acute stroke, especially outside the hospital. Increasing the awareness of the patients about the symptoms of stroke and early treatment techniques will help to reduce mortality and morbidity.
Keywords
References
- Ropper AH, Brown RH. Cerebrovascular diseases. Adams and Victor’s principles of Neurology 2005; 10: 778-884.
- Hankey G. Preventable stroke and stroke prevention. J Thrombosis Haemostasis 2005; 3: 1638-45.
- Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology 2015; 45: 161-76.
- Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circulat Res 2017; 120: 472-95.
- (Tuik) TİK. Ölüm Nedeni İstatistikleri. http: //www.tuik.gov.tr/PreHaberBultenleri.do?id=30626 Erişim: 25.11.2019 2018.
- Şahan M, Satar S, Koç AF, Ahmet S. İskemik inme ve akut faz reaktanları. Arşiv Kaynak Tarama Derg 2010; 19: 85-140.
- Lees KR, Bluhmki E, Von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. The Lancet 2010; 375: 1695-703.
- Fransen PS, Berkhemer OA, Lingsma HF, et al. Time to reperfusion and treatment effect for acute ischemic stroke: a randomized clinical trial. JAMA Neurol 2016; 73: 190-6.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Publication Date
January 12, 2023
Submission Date
September 19, 2022
Acceptance Date
November 29, 2022
Published in Issue
Year 2023 Volume: 6 Number: 1











